Has Synergy Pharmaceuticals Become A Takeout Candidate Following 2 Recent Phase 3 Trial Successes?
December 23, 2016 at 10:50 AM EST
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) has announced the results from its second pivotal Phase 3 trial for plecanatide in ...